169 related articles for article (PubMed ID: 17366603)
1. Expression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival.
Ye C; Cai Q; Dai Q; Shu XO; Shin A; Gao YT; Zheng W
Cancer; 2007 May; 109(9):1729-35. PubMed ID: 17366603
[TBL] [Abstract][Full Text] [Related]
2. Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells.
Lim D; Jocelyn KM; Yip GW; Bay BH
Cancer Lett; 2009 Apr; 276(1):109-17. PubMed ID: 19062161
[TBL] [Abstract][Full Text] [Related]
3. Emodin, aloe-emodin and rhein induced DNA damage and inhibited DNA repair gene expression in SCC-4 human tongue cancer cells.
Chen YY; Chiang SY; Lin JG; Yang JS; Ma YS; Liao CL; Lai TY; Tang NY; Chung JG
Anticancer Res; 2010 Mar; 30(3):945-51. PubMed ID: 20393018
[TBL] [Abstract][Full Text] [Related]
4. Expression status of ataxia-telangiectasia-mutated gene correlated with prognosis in advanced gastric cancer.
Kang B; Guo RF; Tan XH; Zhao M; Tang ZB; Lu YY
Mutat Res; 2008 Feb; 638(1-2):17-25. PubMed ID: 17928013
[TBL] [Abstract][Full Text] [Related]
5. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
Hall J
Cancer Lett; 2005 Sep; 227(2):105-14. PubMed ID: 16112413
[TBL] [Abstract][Full Text] [Related]
6. Variation of ATM protein expression in response to irradiation of lymphocytes in lung cancer patients and controls.
Jianlin L; Jiliang H; Lifen J; Wei Z; Zhijian C; Shijie C; Shijie X
Toxicology; 2006 Jul; 224(1-2):138-46. PubMed ID: 16737764
[TBL] [Abstract][Full Text] [Related]
7. Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in Taiwanese females.
Wang HC; Chang WS; Tsai RY; Tsai CW; Liu LC; Su CH; Cheng HN; Tsou YA; Sun SS; Lin CC; Bau DT
Anticancer Res; 2010 Dec; 30(12):5217-21. PubMed ID: 21187516
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival.
Shin A; Ren Z; Shu XO; Cai Q; Gao YT; Zheng W
Breast Cancer Res Treat; 2007 Sep; 105(1):55-61. PubMed ID: 17066319
[TBL] [Abstract][Full Text] [Related]
9. [Ataxia-telangiectasia mutated gene and breast cancer susceptibility].
Zhang N; Che J; Bai S; Wu Z; Cui Y; Zou W
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):9-15. PubMed ID: 20353086
[TBL] [Abstract][Full Text] [Related]
10. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
11. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies.
Lu PH; Wei MX; Si SP; Liu X; Shen W; Tao GQ; Chen MB
Breast Cancer Res Treat; 2011 Feb; 126(1):141-8. PubMed ID: 20665102
[TBL] [Abstract][Full Text] [Related]
12. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
Micol R; Ben Slama L; Suarez F; Le Mignot L; Beauté J; Mahlaoui N; Dubois d'Enghien C; Laugé A; Hall J; Couturier J; Vallée L; Delobel B; Rivier F; Nguyen K; Billette de Villemeur T; Stephan JL; Bordigoni P; Bertrand Y; Aladjidi N; Pedespan JM; Thomas C; Pellier I; Koenig M; Hermine O; Picard C; Moshous D; Neven B; Lanternier F; Blanche S; Tardieu M; Debré M; Fischer A; Stoppa-Lyonnet D;
J Allergy Clin Immunol; 2011 Aug; 128(2):382-9.e1. PubMed ID: 21665257
[TBL] [Abstract][Full Text] [Related]
13. Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance.
Cheng S; Douglas-Jones A; Yang X; Mansel RE; Jiang WG
Cancer Genomics Proteomics; 2010; 7(2):67-73. PubMed ID: 20335520
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
Lee KM; Choi JY; Park SK; Chung HW; Ahn B; Yoo KY; Han W; Noh DY; Ahn SH; Kim H; Wei Q; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):821-5. PubMed ID: 15824150
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer in female carriers of ATM gene alterations: outcome of adjuvant radiotherapy.
Meyer A; John E; Dörk T; Sohn C; Karstens JH; Bremer M
Radiother Oncol; 2004 Sep; 72(3):319-23. PubMed ID: 15450731
[TBL] [Abstract][Full Text] [Related]
16. [Radiosensitization of nasopharyngeal carcinoma cell line CNE1 by inhibiting the expression of ATM/PI3K functional region].
Wang HM; Chen LH; Zheng XK; Li QS; Wu XY; Xia YF
Ai Zheng; 2006 Sep; 25(9):1097-101. PubMed ID: 16965649
[TBL] [Abstract][Full Text] [Related]
17. The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma.
Bose S; Yap LF; Fung M; Starzcynski J; Saleh A; Morgan S; Dawson C; Chukwuma MB; Maina E; Buettner M; Wei W; Arrand J; Lim PV; Young LS; Teo SH; Stankovic T; Woodman CB; Murray PG
J Pathol; 2009 Feb; 217(3):345-52. PubMed ID: 19142888
[TBL] [Abstract][Full Text] [Related]
18. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.
Bogdanova N; Cybulski C; Bermisheva M; Datsyuk I; Yamini P; Hillemanns P; Antonenkova NN; Khusnutdinova E; Lubinski J; Dörk T
Breast Cancer Res Treat; 2009 Nov; 118(1):207-11. PubMed ID: 18807267
[TBL] [Abstract][Full Text] [Related]
19. The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase.
Treilleux I; Chapot B; Goddard S; Pisani P; Angèle S; Hall J
Histopathology; 2007 Jul; 51(1):63-9. PubMed ID: 17593081
[TBL] [Abstract][Full Text] [Related]
20. Histopathological features of breast cancer in carriers of ATM gene variants.
Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
